Physician profile
Thelsa T Weickert
NPI 1447450143
$19,059.27
in general payments reported to CMS, 2019-2025
13 companies · $2,169 in 2025
The $2,169 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $112 · 2022: $488 · 2023: $8,615 · 2024: $7,545 · 2025: $2,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,207 · Honoraria: $4,500 · Food and Beverage: $2,632 · Travel and Lodging: $2,341 · Consulting Fee: $1,650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,206.50 |
| Honoraria | $4,500.00 |
| Food and Beverage | $2,631.78 |
| Travel and Lodging | $2,341.22 |
| Consulting Fee | $1,650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6,882.07 | 2022-2025 | Lifevest |
| Pfizer INC. | $6,439.87 | 2024-2025 | |
| Genzyme Corporation | $2,412.50 | 2023 | |
| Edwards Lifesciences Corporation | $1,586.87 | 2022-2025 | Pascal, Evoque |
| Novo Nordisk INC | $573.26 | 2022-2024 | Ozempic |
| Abbott Laboratories | $394.31 | 2020-2023 | Mitraclip, Portico |
| Boston Scientific Corporation | $321.74 | 2021-2025 | Watchman Flx, Watchman Access System |
| Medtronic, INC. | $153.42 | 2024 | Symplicity G3 |
| Biosense Webster, INC. | $125.09 | 2024 | Nuvision Ice Catheter, Qdot Micro Catheter |
| E.R. Squibb & Sons, L.L.C. | $86.45 | 2022 | |
| Inari Medical, INC. | $31.73 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $26.37 | 2024 | Repatha |
| Recor Medical INC | $25.59 | 2024 | Paradise Renal Denervation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thelsa Weickert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.